OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Continuous Subcutaneous Foslevodopa‐Foscarbidopa in Parkinson's Disease: A Mini‐Review of Current Scope and Future Outlook
Mickael Aubignat, Mélissa Tir
Movement Disorders Clinical Practice (2024) Vol. 11, Iss. 10, pp. 1188-1194
Open Access | Times Cited: 7
Mickael Aubignat, Mélissa Tir
Movement Disorders Clinical Practice (2024) Vol. 11, Iss. 10, pp. 1188-1194
Open Access | Times Cited: 7
Showing 7 citing articles:
Levodopa Pharmacokinetics in Switching from Levodopa/Carbidopa Intestinal Gel to Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion in a Patient with Parkinson's Disease: a case report
Tomonori Nukariya, Toshiki Tezuka, Shohei Okusa, et al.
Journal of Movement Disorders (2025)
Open Access | Times Cited: 1
Tomonori Nukariya, Toshiki Tezuka, Shohei Okusa, et al.
Journal of Movement Disorders (2025)
Open Access | Times Cited: 1
Device-assisted therapies for Parkinson disease.
Nadia Mouchaileh, Jillian M. Cameron
PubMed (2025) Vol. 48, Iss. 1, pp. 10-17
Closed Access
Nadia Mouchaileh, Jillian M. Cameron
PubMed (2025) Vol. 48, Iss. 1, pp. 10-17
Closed Access
Managing impulse control and related behavioral disorders in Parkinson’s disease: where we are in 2025?
Leonardo Rigon, Carmelo Fogliano, К. Ray Chaudhuri, et al.
Expert Review of Neurotherapeutics (2025)
Closed Access
Leonardo Rigon, Carmelo Fogliano, К. Ray Chaudhuri, et al.
Expert Review of Neurotherapeutics (2025)
Closed Access
Managing cognitive impairment in Parkinson’s disease: an update of the literature
Jennifer G. Goldman, Priya Jagota, Elie Matar
Expert Review of Neurotherapeutics (2025), pp. 1-21
Closed Access
Jennifer G. Goldman, Priya Jagota, Elie Matar
Expert Review of Neurotherapeutics (2025), pp. 1-21
Closed Access
Advanced Parkinson’s disease and eligibility for device-aided therapies in Morocco: a multicenter cross-sectional study
Mohamed Daghi, Zineb Serhier, Abdelhakim Lakhdar, et al.
Neurodegenerative Disease Management (2025), pp. 1-12
Closed Access
Mohamed Daghi, Zineb Serhier, Abdelhakim Lakhdar, et al.
Neurodegenerative Disease Management (2025), pp. 1-12
Closed Access
Device-aided therapies (DATs) in Parkinson’s disease (PD). The DATs-PD GETM Spanish Registry Protocol Study
Diego Santos‐García, Guillermo González‐Ortega, Pilar Sánchez Alonso, et al.
PLoS ONE (2025) Vol. 20, Iss. 3, pp. e0316052-e0316052
Open Access
Diego Santos‐García, Guillermo González‐Ortega, Pilar Sánchez Alonso, et al.
PLoS ONE (2025) Vol. 20, Iss. 3, pp. e0316052-e0316052
Open Access
Foslevodopa/Foscarbidopa: A Review in Advanced Parkinson’s Disease
Hannah A. Blair
CNS Drugs (2025)
Closed Access
Hannah A. Blair
CNS Drugs (2025)
Closed Access
